Androgen Deficiency
13
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Predictors of Androgen Status Decline in Middle-Aged Men
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Cross-sectional Study of 1200 Recreational Athletes With Former or Current Use of Androgenic Anabolic Steroids
Pioglitazone and Insulin Resistance in ADT
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Physical Exercise for Men With Andropause
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
Registry of Hypogonadism in Men
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males